2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:ATCCode |
L01AA01
|
| gptkbp:CASNumber |
50-18-0
|
| gptkbp:excretion |
gptkb:kidney
|
| gptkbp:hasInChIKey |
OFVCZSPXISEYQJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C5H11ClN2O2P
|
| gptkbp:hasSMILES |
C1CN(P(=O)(N1)NCCCl)CC
|
| gptkbp:hasTherapeuticUse |
antineoplastic agent
immunosuppressant |
| gptkbp:hasUNII |
8N3DW7272P
|
| https://www.w3.org/2000/01/rdf-schema#label |
2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
261.1 g/mol
|
| gptkbp:otherName |
gptkb:Cyclophosphamide
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:PubChem_CID |
2907
CHEMBL54 DB00531 |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:phosphoramide_mustard
|
| gptkbp:bfsLayer |
7
|